Now were learning that in osteoarthritis associated with obesity, metabolic syndrome causes inflammation by activating small proteins called cytokines that activate or calm down the immune system, right in the synovium area the space in a joint, your knee for example, bringing white blood cells, or macrophages, rushing in, another sign of inflammation
To these is now added a new class of oral drugs, tyrosine kinase two inhibitors, such as Deucravacitinib, approved by regulatory authorities to offer potent systemic efficacy with the convenience of oral administration, representing a valid alternative for patients who prefer to avoid injections
These warnings, as well as knowledge of the negative secondary ocular outcomes in the large diabetes clinical trials, likely play a role in the referrals to eye clinics for retinal examinations from internists
Sergey Terushkin, MD, FACS is a board-certified bariatric surgeon and medical weight loss specialist practicing in Florida
Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure